Markets
Moderna In Warsaw
Moderna logo seen in Warsaw, Poland, on April 9, 2025 (Jakub Porzycki/Getty Images)

Moderna jumps after reporting much smaller Q3 loss than feared; sales also beat estimates

The company reported earnings results on Thursday.

J. Edward Moreno

Moderna rose in premarket trading after it reported third-quarter results that crushed Wall Street estimates.

The company reported a loss per share of $0.51, significantly less than the $2.21 loss per share analysts polled by Bloomberg were expecting on average, reflecting an aggressive cost-cutting campaign. In fact, that’s a better result than any one of the 18 analysts who submitted an earnings estimate had anticipated.

It also reported $1 billion in sales, more than the $879.6 million the Street was penciling in. Still, Moderna nudged the midpoint of its range of guidance for annual sales lower, to $1.8 billion from $1.85 billion.

The sales numbers may quell investor fears over how much the US Centers for Disease Control and Preventions new, narrower recommendation for when COVID-19 booster shots are appropriate could hurt sales.

Moderna is perhaps best known for being tapped by the US government to quickly develop a vaccine for COVID-19 in 2020, which remains its main source of revenue.

But the company has yet to add new products to its portfolio and is faced with a second Trump administration hostile to vaccines. Last month, the company disclosed that it was cutting development of a vaccine designed to prevent birth defects caused by cytomegalovirus, or CMV, after disappointing trial results.

Moderna rose more than 5% in premarket trading after the earnings report was released. Its down more than 40% since the start of the year.

More Markets

See all Markets
markets

SpaceX gets a wave of bullish ratings from Wall Street analysts

SpaceX received more than a dozen positive analyst calls on Tuesday — including from major Wall Street banks — as they initiate coverage on Elon Musk’s space and AI company.

SpaceX went public on June 12 at a $2.2 trillion valuation, the largest debut in history. While the company hasn’t yet posted a profit, it seems to have convinced Wall Street that it will get there and grow its valuation on the way.

Of the at least 17 analysts that gave a rating on Tuesday, all but one gave it a “buy” or “outperform” rating. MoffettNathanson was "neutral."

The ratings come as SpaceX joined the Nasdaq 100 index, a benchmark tech-heavy basket of companies that underpins millions of portfolios. The inclusion adds built-in demand for the stock from index funds and ETFs.

Still, SpaceX fell more than 5% on Tuesday amid a broader sell-off, and is currently effectively flat from its opening price of $150 a share.

markets

Nike sinks to lowest level since 2014 after warning of “challenged” sales environment in Q4 report

Did Nike do it?

Investors had a mixed reaction after the global sports apparel company reported its fourth quarter earnings on Tuesday after the bell. Shares initially rose 5% as Nike beat out Wall Street expectations amid a hefty tariff refund bonus. However, the stock then sank to its lowest level since August 2014 in postmarket trading.

Here are the Q4 numbers:

  • Revenue of $11.0 billion (estimate: $10.8 billion).

  • Adjusted earnings per share of $0.20 (estimate: $0.12).

Ahead of this report, Nike warned that results would be flattered by a one-time tariff refund (now estimated at roughly $0.52 per share for the bottom line). That gave the company an extra cushion in snapping its streak of seven quarters of year-over-year profit declines.

Over the past year, the company had been punished by tariffs on imported goods, stagnant consumer spending, and increasing competition from other footwear brands like New Balance, Adidas, and Hoka.

Outgoing CFO Matthew Friend deemed it an “increasingly challenging operating environment, where sell-through remains challenged.”

Latest Stories

Sherwood Media, LLC and Chartr Limited produce fresh and unique perspectives on topical financial news and are fully owned subsidiaries of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Money, LLC, Robinhood U.K. Ltd, Robinhood Derivatives, LLC, Robinhood Gold, LLC, Robinhood Asset Management, LLC, Robinhood Credit, Inc., Robinhood Ventures DE, LLC and, where applicable, its managed investment vehicles.